secwatch.observer — SEC 8-K summary
======================================

Issuer:     LENSAR, Inc. (LNSR)
CIK:        0001320350
Form:       8-K
Filed at:   2022-09-08T23:59:59+00:00
Accession:  0000950170-22-018210
Event type: regulatory
Sentiment:  neutral
Materiality: 0.65
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LENSAR applies for CE Mark certification of ALLY System in European Union
-------------------------------------------------------------------------

- Application for CE Mark certification of the ALLY Adaptive Cataract Treatment System submitted.
- CE Mark would allow commercialization of ALLY in the European Union following successful certification.
- Application follows U.S. FDA clearance of ALLY in June 2022 and the U.S. commercial launch.
- Company plans to use distributor network for EU commercialization, similar to first-generation system.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1320350/000095017022018210/0000950170-22-018210-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1320350/000095017022018210/lnsr-20220908.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-018210

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer